StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer GAAP Effective Income Tax Rate by Year

GAAP Effective Income Tax Rate (%) (%)

Pfizer GAAP Effective Income Tax Rate: -350.0% in FY2025, down 310.0 pts from a year earlier.

Latest, FY2025
-350.0%
Period ended Dec 31, 2025
Change on a year earlier
-310.0 pts
-40.0% in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-Q / 10-K Taxes on Income Footnote.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP Effective Income Tax Rate (%) (%)Year on yearSource
FY2025Dec 31, 2025-350.0%-310.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 2024-40.0%+10500.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 2023-10,540.0%-11500.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 2022960.0%+200.0 ptsForm 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 2021760.0%+230.0 ptsForm 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 2020530.0%+10.0 ptsForm 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 2019520.0%+1260.0 ptsForm 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 2018-740.0%+6610.0 ptsForm 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 2017-7,350.0%-8690.0 ptsForm 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 20161,340.0%-880.0 ptsForm 10-K (filed 2019-02-28) ↗
FY2015Dec 31, 20152,220.0%–Form 10-K (filed 2018-02-22) ↗

Cite this data

StockData. (2026). Pfizer GAAP Effective Income Tax Rate (%), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/tax-eff-rate

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.